The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
A practical guide to large-scale docking
Open accessAbstract
Structure-based docking screens of large compound libraries have become common in early drug and probe discovery. As computer efficiency has improved and compound libraries have grown, the ability to screen hundreds of millions, and even billions, of compounds has become feasible for modest-sized computer clusters. This allows the rapid and cost-effective exploration and categorization of vast chemical space into a subset enriched with potential hits for a given target. To accomplish this goal at speed, approximations are used that result in undersampling of possible configurations and inaccurate predictions of absolute binding energies. Accordingly, it is important to establish controls, as are common in other fields, to enhance the likelihood of success in spite of these challenges. Here we outline best practices and control docking calculations that help evaluate docking parameters for a given target prior to undertaking a large-scale prospective screen, with exemplification in one particular target, the melatonin receptor, where following this procedure led to direct docking hits with activities in the subnanomolar range. Additional controls are suggested to ensure specific activity for experimentally validated hit compounds. These guidelines should be useful regardless of the docking software used. Docking software described in the outlined protocol (DOCK3.7) is made freely available for academic research to explore new hits for a range of targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Within the chemoinformatics space, there are advances in computationally modeling how small molecules and proteins interact via docking.157–159”
From Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882 · cited 6×
“To view this fi le in a protein visualization application, they fi rst must be converted to a pdb fi le. csh $DOCKBASE/proteins/showsphere/doshowsph.csh matching_spheres.sph 1 matching_spheres.pdb Input: matching_spheres.sph Output: matching_spheres.pdb The output fi le, matching_spheres.pdb , can be visualized with the r…”
MethodInfluentialTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
The Cambridge Structural Database
Groom, C. R., Bruno, I. J., Lightfoot, M. P., & Ward, S. C. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616003954 · Cited by 10,297 · cited 2×
“We recently proposed a computational tool that estimates torsion strain energies based on experimentally determined torsional populations in the Cambridge Structural Dataset 129,130 Interaction patterns Speci fi c interactions to key residues are main features of promising candidates.”
MethodExtended-Connectivity Fingerprints
Rogers, D. O. W., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,925
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 7,012 · cited 1×
“Visual examination can catch these strained compounds, but various tools have been developed to systematically analyze hundreds or thousands of compounds making them useful in this setting 127 – 129 .”
MethodDevelopment and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,207
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,340
Comparative Protein Structure Modeling Using Modeller
Eswar, N., Webb, B., Martı́-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Šali, A. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0506s15 · Cited by 4,618
Comparative Protein Structure Modeling Using MODELLER
Webb, B., & Šali, A. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.3 · Cited by 4,404 · cited 1×
“Common programs used for homology modeling include Modeller 52 , Rosetta 53 , ICM 27 and I-Tasser 54 .”
Method
Research works printed but not linked: 2
- Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221–234 (2013). · DOI
- Alon, A. et al. Crystal structures of the σ 2 receptor template large-library docking for selective chemotypes active in vivo. Preprint at bioRxiv https://doi.org/10.1101/2021.04.29.441652 (2021). · DOI
Cited by
Sorted by citations
Items 401–500 of 554
How Many Crystal Structures Do You Need to Trust Your Docking Results?
Payne, A. M., Kaminow, B., MacDermott-Opeskin, H., Pulido, I., Scheen, J., Castellanos, M. A., Fearon, D., Chodera, J. D., & Singh, S. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03559 · Cited by 1
Hasija, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15250-4.00007-1 · Cited by 1
Equilibrium and Nonequilibrium Methods for Free-Energy Calculations With Molecular Dynamics
Chipot, C. J., Gkeka, P., Tony Lelièvre, A., & Stoltz, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821978-2.00112-4 · Cited by 1
Mushtaq, M., Usmani, S., Jabeen, A., Nur‐e‐Alam, M., Ahmed, S., Ahmad, A., & Ul‐Haq, Z. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10709-4 · Cited by 1
“The purpose of this activity was to counter under sampling of possible configurations, and inaccurate approximation of docking score because of placement bias [30].”
Ong, C. H., Ling, T. C., Harith, H. H., Firdaus, N., & Israf, D. A. (2023) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.19.5.4 · Cited by 1
Narjes, F., Pairaudeau, G., & Petrović, D. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00682 · Cited by 1
Smith, L. G., Novak, B., Osato, M., Mobley, D. L., & Bowman, G. R. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.1203 · Cited by 1
Mudimela, S., Giridharan, V. V., & Saravanan, J. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301260 · Cited by 1
Considerations Around Structure-Based Drug Discovery for KRAS Using DOCK
Chakrabarti, M., Tan, Y. S., & Balius, T. E. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3822-4_6 · Cited by 1
Self-citationKaltbeitzel, J., Kersten, C., & Wich, P. R. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00635b · Cited by 1
Gulati, I., Tripathi, S., & Tiwari, S. S. (2024) · Springer eBooks · doi:10.1007/978-981-97-1912-9_15 · Cited by 1
Aborode, A. T., Ayobami, O. I., Danazumi, A. U., Olowosoke, C. B., Umar, H. I., Osinuga, A., Awaji, A. A., Awaji, F. A., Omojowolo, E. A., Kuthi, N. A., et al. (2024) · Genome Instability & Disease · doi:10.1007/s42764-024-00141-9 · Cited by 1
“In this study, the co-crystallized ligand within the protein model structure was used as a landmark to locate the protein’s binding site (Ban et al., 2018, Bender et al., 2021).”
Increase Docking Score Screening Power by Simple Fusion With CNNscore
Liang, H., Xie, A., Hou, N., Wei, F., Gao, T., Li, J., Gao, X., Shi, C., Xiao, G., & Xu, X. (2025) · Journal of Computational Chemistry · doi:10.1002/jcc.70060 · Cited by 1
Hassan, F., Ansari, W. A., Sheikh, S. Y., Khan, M. F., Faruqui, T., Azad, I., Siddiqui, M. A., Al-Khedhairy, A. A., Khan, A. R., & Nasibullah, M. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102303 · Cited by 1
Aziz, U., & Jabeen, I. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324677 · Cited by 1
“The Racemic compounds might provide misleading activity values as either one of the enantiomers could have high activity while the other one could have minimal contribution to the activity [38].”
Xue, Y., Liu, M., Wang, K., Yang, Y., Cheng, Y., Ma, X., & Qiao, Y. (2025) · CHAIN · doi:10.23919/chain.2025.000010 · Cited by 1
Samsuri, A., Hermawan, F., Zikri, A. T., Vifta, R. L., & Puspitasari, A. D. (2025) · JURNAL MASYARAKAT INFORMATIKA · doi:10.14710/jmasif.16.2.73574 · Cited by 1
Tarazona, M. Y. C., & Miscione, G. P. (2026) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2025.1731262 · Cited by 1
Assessment of AlphaFold structures and optimization methods for virtual screeningPreprint
Peng, Y., Wu, X., Lin, L., Deng, Z., Zhao, L., & Hao, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.10.523376 · Cited by 1
DOCK Blaster 2.0 - Automated Optimization of Docking Models using Retrospective DockingPreprint
Knight, I., Tang, K. G., Mailhot, O., & Irwin, J. J. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-6h2c9-v2
Self-citationUnbiased MD simulations characterize lipid binding to lipid transfer proteinsPreprint
Srinivasan, S., Lorenzo, D. A., & Vanni, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.24.568550 · Cited by 1
da Silva, M. M. P., Guedes, I. A., Custódio, F. L., & Dardenne, L. E. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-f4q6k · Cited by 1
The power and limits of predicting exon-exon interactions using protein 3D structuresPreprint
Liebold, J., Moral‐Morales, A. D., Manalastas-Cantos, K., Tsoy, O. V., Kurtz, S., Baumbach, J., & Newaz, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.01.582917 · Cited by 1
ApoDock: Ligand-Conditioned Sidechain Packing for Flexible Molecular DockingPreprint
Luo, D., Qu, X., Lu, D., Wang, Y., Dong, L., & Wang, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.22.624942 · Cited by 1
Optimising the β-lactam Parameters Using the ForceField ToolkitPreprint
Wu, Q., Xia, S., Otto, F., Lee, T.-Y., Huang, H., & Chiang, Y. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-dpcbt
Considerations and Challenges for Sex-Aware Drug RepurposingPreprint
Fisher, J., Jones, E., Flanary, V. L., Williams, A. A., Ramsey, E., & Lasseigne, B. N. (2022) · Preprints.org · doi:10.20944/preprints202112.0380.v2
Hernández, C. C., Tarfa, R. A., Limcaoco, J. M. I., Liu, R., Mondal, P., Hill, C., Duncan, R. K., Tzounopoulos, T., Stephenson, C. R. J., O’Meara, M. J., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4086889
Matos, I. D. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-02122022-154640
Busania, V. N., Canilao, D. M. C., Endriga, M. A., & Frio, E. J. L. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995433
“Polar hydrogen and Kollman charges were added to simulate the optimum environment of the receptor-ligand complex [26].”
BackgroundMolecular docking: Finding potential antiviral against emerging diseases
Pande, T., Vasavi, K., Upmanyu, V., & Tiwari, A. K. (2022) · Indian Journal of Comparative Microbiology Immunology and Infectious Diseases · doi:10.5958/0974-0147.2022.00021.6
Rayka, M., Latifi, A. M., & Mirzaei, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3016067/v1
Percudani, R., Malatesta, M., Zangelmi, E., Peracchi, A., Secchi, A., Fornasier, E., Gabriele, G., Battistutta, R., di Salvo, M. L., Contestabile, R., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3295520/v1
Targeting AML Growth: Vitamins' Influence on FLT3, NPM1, and RUNX1 InteractionsPreprint
Dasgupta, T., Chatterjee, R., Mondal, M., Sen, S., Banik, S., Pati, S., Chell, G. C., Chakraborty, S., Mondal, S., Sen, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3799347/v1
de Oliveira, M. D. A., Beltrão, G. S., Pinto, A. R., & Silveira, D. B. (2024) · Instituto de Inteligência em Pesquisa e Consultoria Cientifica Ltda eBooks · doi:10.56041/9786599841859-7
Tendências Biotecnológicas Sustentáveis para Fins de Saúde Única
(2024) · Instituto de Inteligência em Pesquisa e Consultoria Cientifica Ltda eBooks · doi:10.56041/9786599841859 · Cited by 1
Structure-based Design for Medicinal Chemists
Blaney, J., & Davis, A. M. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00137
Balaji, M. P., & Rajeswari, V. D. (2024) · Research Square · doi:10.21203/rs.3.rs-3990166/v1
Priya, R. H., & Vasan, P. T. (2024) · Indian Journal of Science and Technology · doi:10.17485/ijst/v17i13.1949
Additional file 4 of Systemic evolutionary chemical space exploration for drug discovery
Lu, C., Liu, S., Shi, W., Yu, J., Zhou, Z., Zhang, X., Lu, X., Cai, F., Xia, N., & Wang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19498423
Additional file 3 of Systemic evolutionary chemical space exploration for drug discovery
Lu, C., Liu, S., Shi, W., Yu, J., Zhou, Z., Zhang, X., Lu, X., Cai, F., Xia, N., & Wang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19498420
Additional file 2 of Systemic evolutionary chemical space exploration for drug discovery
Lu, C., Liu, S., Shi, W., Yu, J., Zhou, Z., Zhang, X., Lu, X., Cai, F., Xia, N., & Wang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19498417
Auli, W. N., Aziz, S., Karim, D. D. A., Evanggeulista, A., Jannah, A. F., & Mendrofa, A. Y. H. (2024) · Acta Pharmaciae Indonesia Acta Pharm Indo · doi:10.20884/1.api.2023.11.2.11704
Investigating the role of mitochondrial energy rewiring throughout prostate cancer progression
Bidgood, C. L. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.248849
Basbaum, A. I., Jensen, T. S., & Keefec, F. J. (2024) · NeuroTarget · doi:10.47924/neurotarget2024468
Gawande, V., Kushwaha, R., Mandal, A. A., & Banerjee, S. (2024) · ChemBioChem · doi:10.1002/cbic.202400612
Micellar curcumol for maintenance therapy of ovarian cancer by activating the FOXO3a
Wang, J., Chen, B., Yang, J., Tang, Q., Zhong, Y., Du, J., Wang, S., Wu, Q., Lu, Y., & Song, Y. (2024) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2024.102789
In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers
Córdova-Bahena, L., Landero-Marín, C., Flores-Hernández, X., Alvarez-Coronel, L. D., Jiménez‐Uribe, A. P., Salinas-Jazmín, N., An, Z., & Velasco-Velázquez, M. A. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206303675241009104647
Rational drug design targeting G-protein-coupled receptors: ligand search and screening (review)
Luginina, A. P., Khnykin, A. N., Khorn, P. A., Moiseeva, O. V., Safronova, N. A., Поспелов, В. А., Dashevskii, D. E., Belousov, A. S., Borshchevskiy, I. V., & Mishin, A. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524050158
Patel, K. (2024) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/y29c2338
The inhibition of baicalein on pancreatic lipase investigated in vitro and in vivo
Peng, R., Hu, M., Xu, H., Wang, W., Yin, Z., Chen, J., & Zhang, Q. (2024) · JSFA reports · doi:10.1002/jsf2.226
Sahni, N., Pátek, M., Rahman, R., & Ravikumar, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628696
-, R. S., -, N. M., & Pandya, P. (2025) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2025.v07i01.35356
“Lastly, the structure is validated by competent research and experimental data [24] 3.3.”
InfluentialComputational Theories Shaping the Future of Drug Discovery
Venkatesh, P. H., Uttarkar, A., & Niranjan, V. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-5598-5.ch006
Li, Y., Zeng, M., Zhu, J., Liu, L., Wang, F., Huang, L.-K., Yang, F., Li, M., & Yao, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.02.635055
Căta, A., Pop, R. O., Antal, D., Ardelean, F., Ruse, G., & Ienașcu, I. M. C. (2025) · Analele Universităţii "Ovidius" Constanţa. Seria Chimie/"Ovidius" University Annals of Chemistry · doi:10.2478/auoc-2025-0003
“In order to perform the molecular docking [34, 35], the following procedure has been performed: the water molecules from the receptor structure have been removed, together with the non-polar hydrogen atoms.”
Assessing the Stability of Molecular Glues with Weighted Ensemble Simulations
Atik, S. B., & Dickson, A. (2026) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6c00319
Gyebi, G. A., & Sabiu, S. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108458
Lin, T. E., Hsu, K., Chou, C.-H., Tsai, E.-Y., Wu, Y., Sung, T.-Y., Hsu, J., Hsieh, J., Yen, S., Chang, Y.-W., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116959
Embedding Security into DevOps
Elbaghazaoui, B. E., & Allaoui, R. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-0365-9.ch008
Kharwar, A., & Tiwari, A. K. (2025) · Research Square · doi:10.21203/rs.3.rs-6532706/v1
Krisnan, K. G., Al-Obaidi, A., Hussin, H., & Zulkifli, R. M. (2025) · Journal of Materials in Life Sciences (JOMALISC) · doi:10.11113/jomalisc.v4.94
“Unnecessary chains and non-protein components were removed from the receptor, as their presence can interfere with docking accuracy [19].”
Akram, H., Rahman, M. U., Mazhar, S., Qamer, F., & Yousaf, A. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2533061
Sciò, P., Bufano, M., Silvestri, R., & Coluccia, A. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01276
Structure Modeling and Virtual Screening with HCAR3 to Discover Potential Therapeutic Molecules
Liu, Y., Peng, Y., Zhao, Z., Guo, Y., Lin, B., & Chiang, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18091290
“Decoys are inactive ligands with similar physicochemical properties to the active compounds; however, their topologies are so different from actives that they should not bind with the target [37,38].”
Large chemical spaces—Modeling and searching of large chemical spaces
Orsi, M., & Reymond, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00045-5
Altê, G. A., & Rodrigues, A. L. S. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_9
Expansion of DNA-Encoded Library Hits Using Generative Chemistry and Ultra-Large Compound CatalogsPreprint
Novy, B., Lin, S.-H., Shell, D. J., Maxfield, T., Merten, E. M., Zhilinskaya, I., Wellnitz, J., Guduru, S. K. R., Hardy, P. B., Pearce, K. H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.30.679600
“22,23 Notably, successful structure-based VS provides a protein-ligand complex model, aiding downstream hit evaluation and optimization.”
Li, X., Ren, K., Baran, M. R., Tang, J., Wang, L., Tchivelekete, G. M., Guo, Y., Bai, Y., Yan, W., & Shu, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333478
“Now, it can perform different tasks during the course of drug discovery, such as hit identification and optimization, prediction of adverse effects, polypharmacology, drug repurposing, and target fishing and profiling [16,17].”
Punia, R., & Goel, G. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01556
Boe, D., Elbrecht, D., Lee, A. A., Robinson, M. C., & Schroeder, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00059-5
García, A. Q., Raïch, I., del Torrent, C. L., Lillo, J., Casajuana-Martín, N., Rebassa, J. B., Navarro, G., & Pardo, L. (2025) · Protein Science · doi:10.1002/pro.70394
“In silico methods, those based on physics such as molecular docking (Bender et al. 2021; Sadybekov and Katritch 2023) or those based on artificial intelligence (Abramson et al. 2024), can successfully predict the interaction of ligands with the orthosteric site (Lyu et al. 2019).”
Shimizu, M., Yoneyama, S., Yanagisawa, K., & Akiyama, Y. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c03067
Ruan, G.-Y., Ye, L.-X., Lin, J.-S., Lin, H.-Y., Yu, L.-R., Wang, C., Xiaodan, M., Zhang, S.-H., & Sun, P.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26575793
Additional file 1 of EasyDock: customizable and scalable docking tool
Minibaeva, G., Ivanová, A., & Полищук, П. Г. (2024) · Figshare · doi:10.6084/m9.figshare.26634585
Ruan, G.-Y., Ye, L.-X., Lin, J.-S., Lin, H.-Y., Yu, L.-R., Wang, C.-Y., Xiaodan, M., Zhang, S.-H., & Sun, P.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26575784
Ruan, G.-Y., Ye, L.-X., Lin, J.-S., Lin, H.-Y., Yu, L.-R., Wang, C.-Y., Xiaodan, M., Zhang, S.-H., & Sun, P.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26575790
Lee, D., Hwang, W., Byun, J., & Shin, B. (2024) · Figshare · doi:10.6084/m9.figshare.27078924
Ruan, G.-Y., Ye, L.-X., Lin, J.-S., Lin, H.-Y., Yu, L.-R., Wang, C.-Y., Xiaodan, M., Zhang, S.-H., & Sun, P.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26575787
Additional file 1 of Systemic evolutionary chemical space exploration for drug discovery
Lu, C., Liu, S., Shi, W., Yu, J., Zhou, Z., Zhang, X., Lu, X., Cai, F., Xia, N., & Wang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19498414
Gyebi, G. A., & Sabiu, S. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11429-7
“For the reliability of docking protocol assessment [57], validation was performed.”
Role of Cheminformatics and Chemometrics in Drug design and Discovery
Amin, S. A. (2025) · Springer handbooks · doi:10.1007/978-3-031-81728-1_3
Assessing the Stability of Molecular Glues with Weighted Ensemble SimulationsPreprint
Atik, S. B., & Dickson, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.23.701371
“It is now possible to acquire such information through structure-based methods such as docking [6, 24], molecular dynamics (MD) simulations [13], and free-energy calculations.”
The power and limits of predicting inter-protein exon-exon interactions using protein 3D structures
Liebold, J., Moral‐Morales, A. D., Manalastas-Cantos, K., Tsoy, O. V., Kurtz, S., Baumbach, J., & Newaz, K. (2026) · Bioinformatics Advances · doi:10.1093/bioadv/vbag032
“However, docking has high computational costs, taking a few minutes to several hours or even days to process one protein pair (Meng et al. 2011, Bender et al. 2021).”
Rapid Parallel Virtual Screening Aids the Discovery of Novel P-Glycoprotein Inhibitors
Moesgaard, L., Pakuła, K., Nielsen, C. U., & Kongsted, J. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02552
Revealing the Binding Mechanism of Gossypol on Bcl‑2 via Funnel Metadynamics Simulations
Zhu, T., He, S., Luo, M., & Wang, W. (2026) · ACS Omega · doi:10.1021/acsomega.5c11622
A framework for testing structural hypotheses of protein dynamics against experimental HDX-MS dataPreprint
Siddiqui, A. I. H., Skyner, R., Musgaard, M., Krishnamurthy, S., Deane, C., & Crook, O. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.02.709114
Owusu, K., Fatao, S., Laryea, M. K., & Borquaye, L. S. (2026) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2026.103998
Afshari, M., Sadeghi, M., Omrani, S., & Lee, S. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108678
LiBRe: A Ligand-Aware Sequence-Based Binding Residue Prediction Model for Virtual Screening
Kang, K., Kim, M., Kim, J., Sel, S., & Song, G. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02883
Ayurvedic-guided Natural Product Discovery as Potential Inhibitors of HIV-1 Proteins
Alqaaf, M., Nasution, A. K., Nilamsari, E. I., Supriyanti, R., Ono, N., Kanaya, S., & Altaf-Ul-Amin, M. (2025) · IEEE International Conference on Future Machine Learning and Data Science (FMLDS) · doi:10.1109/fmlds67896.2025.00112
“…a single, high-quality PDB entry from each of the five clusters based on three criteria: (i) the highest available crystallographic resolution [15], (ii) completeness of the ligand-binding site (or nucleic acid interface) [16], and (iii) the presence of a co-crystallized ligand or substrate…”
Evteev, S. A., Sizov, F., Pastukhova, A. S., Ereshchenko, A., Adjugim, D., & Ivanenkov, Y. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11521-6
“These factors are known to be advantageous for utilizing computational algorithms to reliably place frag - ments within the binding pocket [ 2 ].”
Nemirov, D., & Ovchinnikov, K. L. (2026) · From Chemistry Towards Technology Step-By-Step · doi:10.52957/2782-1900-2026-7-1-125-135
Nemirov, D., & Ovchinnikov, K. L. (2026) · From Chemistry Towards Technology Step-By-Step · doi:10.52957/2782-1900-2026-7-1-43-53
Jadhav, Y., Mukadam, S., Bhingoli, O., Unavane, S., Kamble, S. C., Naidu, P., Girme, A., Mali, A., & Shinde, V. R. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00625-4
Koprowski, P., Miszta, P., Strawa, J. W., Krempovych, Y., Ziajowska, A., Filipek, S., Szewczyk, A. M., & Tomczyk, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.720584
“…with published guidance that docking is most reliable for generating interaction hypotheses and prioritizing poses for subsequent validation, while scoring functions and rank ordering can be unreliable for quantitative affinity prediction (Bender et al., 2021; Ramírez and Caballero, 2016).”
Mitjavila-Domènech, N., Díaz‐Holguín, A., Hu, H., Kahlous, N. A., de Vaca, I. C., Wallner, B., & Carlsson, J. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00034
“64 Finally, one or a small set of top-ranked models is selected for prospective virtual screening of large compound libraries.”
Self-citationNguyen, H. H., Xie, B., & Minh, D. D. L. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00077
Fungal metabolite-based immunotherapy overcomes tumor-associated macrophage immunosuppression
Hu, J., Ju, X., Deng, B., Tang, K., Yuan, D., Sun, X., Kong, L., Xu, Y., Fu, Z., Koda, S., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102833
(+)- trans -Cannabidiol is a CB 2 receptor agonistPreprint
Burtchaell, P. B., Santiago, M., Wang, C., Hagdoost, M., Clay, E. J. M., Mohnot, D., & Connor, M. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.25.727077
“Among these, the 8GUR structure was selected as it provided the most accurate activity predictions for a benchmark set of active and decoy CB 2 ligands (32).”
Jain, S., Yasgar, A., Dalal, A., Nilova, A., Davies, M., Baljinnyam, B., Qu, Y., Denson, J.-P., Esposito, D., Tao, D., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00537
Metadata
- Authors
- Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., & Shoichet, B. K.
- Affiliations
- University of California, San Francisco (US)
- Uppsala University (SE)
- Frederick National Laboratory for Cancer Research (US)
- Corresponding author
- Shoichet, Brian K.
- ORCID
- Venue
- Nature Protocols
- Published
- 2021-09-24
- Volume
- 16
- Issue
- 10
- Pages
- 4799-4832
- ISSN
- 1750-2799 (ISSN-L)
- 1754-2189
- PMC
- PMC8522653
- OpenAlex
- W3201539868
- Cited by
- 546
- References
- 145
- Citations by year
- 2026: 96 · 2025: 123 · 2024: 140 · 2023: 117 · 2022: 66 · 2021: 4
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-12-09)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Protocols (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH112205)
- National Institute on Drug Abuse (R37DA045657)
- National Institute of General Medical Sciences (T32GM008284, R01GM133836, F32GM136062, T32GM007175, R35GM122481)
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK116195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- structure-based virtual screening, binding energy prediction, melatonin receptors, hit identification, cluster computing, drug discovery
- MeSH terms
- Ligands, Software, Drug Design, Drug Discovery, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review